PERJETA should be discontinued if trastuzumab or trastuzumab hyaluronidase-oysk treatment is discontinued. Dose reductions are not recommended for PERJETA. For chemotherapy dose modifications, see relevant prescribing information. Left Ventricular Ejection Fraction (LVEF)
PERJETA and trastuzumab can be given in any order.1,2 Please see the. PERJETA full Prescribing Information for additional dosing information for PERJETA
Perjeta (pertuzumab). The purpose of this form is to obtain information Have the prescribing physician complete the Physician Information sections.
These highlights do not include all the information needed to use PERJETA safely and effectively. See full prescribing information for PERJETA. PERJETA (pertuzumab) Injection, for intravenous use Initial U.S. Approval: 2024 . WARNING: CARDIOMYOPATHY and EMBRYO-FETAL TOXICITY See full prescribing information for complete boxed warning.
PERJETA Prescribing Information. Genentech, Inc. 2024. THERE'S MORE TO. EXPLORE IN THE. TREATMENT OF HER2. EARLY BREAST CANCER.
PERJETA (pertuzumab) is a prescription PERJETA. Please see full Prescribing Information for additional Important Safety Information, including most serious
by C Jackisch 2024 Cited by 144. Genentech, Inc. PERJETA (pertuzumab). Prescribing information. 2024. Accessed .
information for AusPAR Perjeta Pertuzumab PERJETA. Trastuzumab dose reductions are not recommended, see trastuzumab prescribing information.
PERJETA (pertuzumab) Abridged Prescribing Information. PERJETA (pertuzumab) 420mg/14mL concentrate solution is a Prescription. Medicine. Neoadjuvant
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.